For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
Scope of the Report:
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units' implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
The worldwide market for Neuromodulation Devices and Implantable Infusion Pumps is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Neuromodulation Devices and Implantable Infusion Pumps in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Boston Scientific Corporation
- St. Jude Medical
- Synapse Biomedical
- Nevro Corporation
- Autonomic Technologies
- Avery Biomedical
- Greatbatch Medical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagal Nerve Stimulation
- Gastric Stimulation
- Transcranial magnetic Stimulation
- Transcutaneous Electrical Stimulation
Market Segment by Applications, can be divided into
- Parkinson's disease
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales, revenue and global market share of Neuromodulation Devices and Implantable Infusion Pumps in 2017 and 2018.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion, appendix and data source.